Combination & Conjugate Vaccines

Increasingly, more diseases are becoming vaccine preventable, but maintaining community and provider acceptance demands that the number of injections doesn’t increase. Combination conjugate vaccines represent an inevitable and important advance. This paper reviews the efficacy and safety of combination conjugate vaccines, including immunological mechanisms underlying interactions among vaccine epitopes, the role of immunological memory, and correlates of immunity. Specific attention is given to the experience with combination vaccines against each of Haemophilus influenzae type bStreptococcus pneumoniae  and Neisseria meningitidis. The implications of these findings for different communities are discussed, key areas for further research identified and implications for post-licensure monitoring addressed.


    Related Conference of Combination & Conjugate Vaccines

    April 04-05, 2024

    38th International Conference on Immunology

    Madrid, Spain
    May 23-24, 2024

    18th International Conference on European Immunology

    Zurich, Switzerland
    October 24-25, 2024

    5th International Conference on Immunology And Immunotherapy

    Zurich, Switzerland

    Combination & Conjugate Vaccines Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in